Benzinga's Top Pre-Market Gainers

Novavax NVAX soared 10.99% to $2.12 in the pre-market trading after the company reported that it had successfully produced MERS-CoV vaccine candidate. Unilife UNIS moved up 7.20% to $3.87 in the pre-market session. Unilife shares have dropped 25.16% over the past 52 weeks, while the S&P 500 index has gained 23.39% in the same period. Clovis Oncology CLVS shares gained 5.59% to $73.81 in the pre-market session. Analysts at JPMorgan lifted price target on the stock from $45 to $88. Transcept Pharmaceuticals TSPT surged 4.97% to $3.17 in the pre-market session. Transcept had $81.08 million in total cash and no debt for the latest quarter.